Found: 5
Select item for more details and to access through your institution.
The impact of hydrocodone rescheduling on utilization, abuse, misuse, and overdose deaths.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 7, p. 735, doi. 10.1002/pds.5603
- By:
- Publication type:
- Article
Effect of US Food and Drug Administration- Approved Pediatric Labeling on Dispensing of Extended-Release Oxycodone in the Outpatient Retail Setting.
- Published in:
- JAMA Pediatrics, 2016, v. 170, n. 11, p. 1103, doi. 10.1001/jamapediatrics.2016.3197
- By:
- Publication type:
- Article
Analysis of Benzonatate Overdoses Among Adults and Children from 1969-2010 by the United States Food and Drug Administration.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 1, p. 38, doi. 10.1002/phar.1153
- By:
- Publication type:
- Article
Drug availability adjustments in population-based studies of prescription opioid abuse.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2017, v. 26, n. 2, p. 180, doi. 10.1002/pds.4139
- By:
- Publication type:
- Article
Repeated or Continuous Medically Supervised Ketamine Administration Associated with Hepatobiliary Adverse Events: A Retrospective Case Series.
- Published in:
- Drug Safety, 2021, v. 44, n. 12, p. 1365, doi. 10.1007/s40264-021-01120-9
- By:
- Publication type:
- Article